Presentations – Cardiovascular Disease

Cohen SS, Chamberlain AM, Killian JM, Monda KL, Weston SA, Okerson T. Monitoring Frequency After the Diagnosis of Diabetes or Atherosclerotic Cardiovascular Disease. Presented at the American Heart Association Scientific Sessions, November 11-15, 2017, Anaheim, CA.

Okerson T, Cohen SS, Killian JM, Weston SA, Monda KL, Chamberlain AM. Changes in Lipid-Lowering Therapy Following a Cardiovascular Event in Patients with Diabetes Mellitus. Presented at the 53rd Annual Meeting of the European Assocation for the Study of Diabetes, September 11-15, 2017, Lisbon, Portugal.

Einstein AJ, Sesso HD, Cohen SS, Boerma M, Chambers C, Darcy S, Gerber TC, Hirshfield J, Little MP, Mulrooney DA, Held KD, Boice JD. Classification of cardiovascular causes of death for radiation epidemiologic studies: initial application to cohorts of radiation workers, radiographers, and atomic veterans. Presented at the European Society of Cardiology Congress 2017, August 26-30, 2017, Barcelona, Spain.

Chamberlain AM, Cohen SS, Killian JM, Weston SA, Okerson T, Monda KL. Changes in Lipid-Lowering Therapy Prescription Patterns following a Second Cardiovascular Disease Event. Presented at the European Society of Cardiology Congress 2017, August 26-30, 2017, Barcelona, Spain.

Cohen SS, Chamberlain AM, Killian JM, Monda KL, Weston SA, Okerson T. Comparison of Lipid-Lowering Treatment in Patients with Diabetes and/or Atherosclerotic Cardiovascular Disease. Presented at the American Diabetes Association’s 77th Scientific Sessions, June 9-13, 2017, San Diego, CA.

Alexander DD. Epidemiology of Egg Consumption and Risk of Coronary Heart Disease and Stroke. Presented at a meeting for the Egg Farmers of Canada, June 6, 2017, Webinar.

Chamberlain AM, Cohen SS, Killian JM, Monda KL, Hedgeman E, Weston SA, Okerson T. Lipid-lowering Therapy Prescription Patterns and Predictors of High Intensity Statin Prescriptions in Patients With Diabetes or Atherosclerotic Cardiovascular Disease. Presented at the American Heart Association’s Epidemiology and Prevention – Lifestyle 2017 Scientific Sessions, March 7, 2017, Portland, OR.

Chamberlain AM, Cohen SS, Killian JM, Beaubrun AC, Monda KL, Hedgeman E, Weston SA, Okerson T. Lipid-Lowering Therapy Prescriptions Immediately Before and After the Diagnosis of Diabetes or Atherosclerotic Cardiovascular Disease. Presented at the American Heart Association Scientific Sessions, November 1, 2016, New Orleans, LA.

Meddings J, Reichert H, Smith SN, et al. How do patient and community-level measures of patient functional status, social support and socioeconomic status compare in predicting the risk of readmission for pneumonia and heart failure? Presented at the Society of General Internal Medicine (SGIM) 2016 Annual Meeting, May 11-14, 2016, Hollywood, FL.

Cohen SS, Shirey-Rice J, Hardin J, Monda K, Fryzek JP, Fazio S, Denny JC, Wei WQ, Lipworth LL. Identification of patients with familial hypercholesterolemia (FH) using the Dutch Lipid Network (DLN) criteria in Electronic Health Records (EHR). Presented at the American Heart Association EPI Lifestyle Scientific Sessions, March 1-4, 2016, Phoenix, AZ.

Cohen SS, Kabagambe EK, Shirey-Rice J, Hardin J, Monda K, Fryzek JP, Fazio S, Denny JC, Wei WQ, Lipworth LL. Achievement of LDL-cholesterol reduction targets is associated with reduced cardiovascular disease risk among patients with familial hypercholesterolemia in a large electronic medical record database. Presented at the American Heart Association 2015 Scientific Sessions, November 7-11, 2015, Orlando, FL.

Meddings J, Reichert H, Smith S, Iwashyna T, Langa K, Hofer T, McGuirk H, McMahon LF Jr. Functional status, social support and wealth impact readmissions for pneumonia and heart failure beyond standard Medicare risk-adjustors. Presented at the 11th International Conference on Health Policy Statistics, October 7-9, 2015, Providence, RI.

Lipworth LL, Shirey-Rice J, Wei WQ, Hardin J, Shi G, Monda K, Fryzek JP, Fazio S, Cohen SS, Denny JC. Identification and characterization of heterozygous familial hypercholesterolemia patients using the Vanderbilt University Medical Center Synthetic Derivative database. Presented at the European Society for Cardiology Congress, August 29 – September 1, 2015, London, United Kingdom.

Meddings J, Reichert H, Smith S, Iwashyna T, Langa K, Hofer T, McGuirk H, McMahon LF Jr. Functional status, social support and wealth impact readmissions for pneumonia and heart failure beyond standard Medicare risk-adjustors. Academy Health Annual Research Meeting, June 14-15, 2015, Minneapolis, MN.

Maki KC, Guyton JR, Orringer CE, Hamilton-Craig I, Alexander DD, Davidson MH. Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemia. Presented at the National Lipid Association Scientific Sessions, June 11-14, 2015, Chicago, IL.

Alexander DD. The epidemiology of red and processed meat consumption and cancer and cardiovascular disease The role of red meats in a healthy diet: U.S Meat Export Federation, October 20, 2010, Mexico City, Mexico.